Search clinical trials for: 0.01% atropine

Total 2256 results

Yungjin Pharm. Co., Ltd.

Completed

A Phase 2a Study to Assess Safety, Daily Symptoms, PK, and Biomarkers of YPL-001 in COPD Patients

Chronic Obstructive Pulmonary Disease

United States
King Hamad University Hospital, Bahrain
Royal College of Surgeons in Ireland - Medical University of Bahrain; Oramed...

Not yet recruiting

Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2
Arcutis Biotherapeutics, Inc.

Completed

Pharmacokinetics (PK), Safety, Efficacy and Maximal Use PK of ARQ-151 in Adolescents/Children With Mild/Moderate Eczema

Atopic Dermatitis (Eczema)

United States
Inovio Pharmaceuticals
Coalition for Epidemic Preparedness Innovations

Completed

Dose-ranging Study: Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers in Ghana

Lassa Fever

Ghana
UMN Pharma Inc.

Completed

Immunogenicity, Safety and Optimal Dose Finding Study of Recombinant Influenza H5N1 Vaccine in Healthy Young Adults

Virus Diseases | Influenza

Japan
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical...

Completed

the Effect of Low-Concentration Atropine Combined With Auricular Acupoint Stimulation in Myopia Control

Myopia

Taiwan
SciTech Development, LLC
Rush University Medical Center

Recruiting

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

Mycosis Fungoides | Cutaneous T-cell Lymphoma | Peripheral T-cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | T-cell Lymphoma | Cutaneous/Peripheral T-Cell Lymphoma | Peripheral T-Cell Lymphoma, Not Classified | Primary Cutaneous T-cell Lymphoma | Cutaneous T-Cell Lymphoma, Unspecified | Follicular... and other conditions

United States
Kintara Therapeutics, Inc.

Recruiting

Efficacy and Safety Study of REM-001 Photodynamic Therapy for Treatment of Cutaneous Metastatic Breast Cancer (CMBC)

Cutaneous Breast Cancer

United States
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Completed

Safety and Efficacy Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)

Hidradenitis Suppurativa

China
DermBiont, Inc.
Derm Research, PLLC; Northsoundderm; ClearDermatologyandAestheticsCenter

Terminated

Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous Gel

Atopic Dermatitis

United States
Vera Therapeutics, Inc.

Suspended

Atacicept in Subjects With Active Lupus Nephritis (COMPASS) (COMPASS)

Lupus Nephritis (LN)

United States, Puerto Rico, Spain
JANSSEN Alzheimer Immunotherapy Research & Development...
Pfizer

Completed

AAB-001 in Patients With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

United States
Dermatrials Research
Johnson & Johnson

Completed

Proof of Concept Study to Investigate the Recurrence of Acne Post Isotretinoin

Acne

Canada
Medical University of Lodz

Not yet recruiting

Atropine vs Isoprenaline in the Invasive Diagnosis of Arrhythmias

Cardiac Arrhythmia | Supraventricular Arrhythmia

Poland
University Hospital Olomouc
Palacky University

Completed

Comparing the Efficiency of Two Approaches in Patients at Risk of Developing Intraoperative Floppy Iris Syndrome

Cataract | Age-related Cataract | Intraoperative Floppy Iris Syndrome | Adrenergic Receptor Antagonist Adverse Reaction

Czechia
Mansoura University

Completed

Intrathecal Atropine vs IV Metoclopramide for Nausea & Vomiting During CS

Nausea | Vomiting

Egypt
New York State Psychiatric Institute
United States Department of Defense

Completed

Olfactory Deficits in MCI as Predictor of Improved Cognition on Donepezil

Mild Cognitive Impairment

United States
Alcon Research

Completed

Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic Conjunctivitis

Allergic Conjunctivitis
GlaxoSmithKline

Completed

Characterisation of T-cell Response to Keyhole Limpet Hemocyanin (KLH) and Tuberculin Purified Protein Derivative (PPD)

Dermatitis

United Kingdom
University of California, San Diego
Center for Medicinal Cannabis Research

Recruiting

Cannabis Effects on Antiretroviral Therapy Pharmacokinetics and Neurotoxicity

HIV | Cannabis Use

United States
Galderma R&D

Completed

Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne

Acne Vulgaris

United States
Acotec Scientific Co., Ltd

Recruiting

Acotec DCB Post Market Clinical Follow-up (FLOWER)

Peripheral Artery Disease

Germany
Viridian Therapeutics, Inc.

Recruiting

A Randomized, Active Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED)

Thyroid Eye Disease

United States
Biokuris s.a.

Recruiting

A 14-week Pilot Prospective Clinical Trial With BiOkuris Product in Patients With Irritable Bowel Syndrome

Irritable Bowel Syndrome

Belgium
Entos Pharmaceuticals Inc.
Canadian Institutes of Health Research (CIHR); Aegis Life, Inc.; Clinical Pharma... and other collaborators

Completed

A Clinical Trial of a Prophylactic Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults

SARS-CoV-2

Burkina Faso, Canada, Senegal, South Africa
Inovio Pharmaceuticals
Coalition for Epidemic Preparedness Innovations

Completed

Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers

Lassa Fever

United States
Light Chain Bioscience - Novimmune SA

Terminated

Primary Biliary Cirrhosis: Investigating A New Treatment Option Using NI-0801, an Anti-CXCL10 Monoclonal Antibody (PIANO)

Primary Biliary Cirrhosis

Italy, United Kingdom
Hadassah Medical Organization
Oramed Pharmaceutical Inc.

Completed

Effectiveness of Oral Insulin in Unstable Type 1 Diabetes Patients

Brittle Type I Diabetes Mellitus

Israel
Light Chain Bioscience - Novimmune SA

Completed

NI-0801 in Allergic Contact Dermatitis

Allergic Contact Dermatitis
X4 Pharmaceuticals

Not yet recruiting

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

Neutropenia
MitoImmune Therapeutics

Recruiting

MIT-001 for Prevention of CCRT-Induced OM in HNSCC Patients (MIT-001)

Head and Neck Squamous Cell Carcinoma | Oral Mucositis

Korea, Republic of, United States
PTC Therapeutics

Completed

A Study of PTC923 (CNSA-001) in Primary Tetrahydrobiopterin (BH4) Deficient Participants With Hyperphenylalaninemia

BH4 Deficiency | Hyperphenylalaninemia

United States
Better Therapeutics
University of Colorado, Denver; CPC Clinical Research; Ascension Health; Department... and other collaborators

Active, not recruiting

Digital Therapeutic Based Investigation to Improve Glycemic Control in Patients With Type 2 Diabetes and Residual Hyperglycemia on Stable Medical Therapy (BRIGHT)

Diabetes Mellitus, Type 2

United States
X4 Pharmaceuticals

Completed

A Dose Determination and Safety Study of X4P-001 (Mavorixafor) in Participants With Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) Syndrome

WHIM Syndrome

Australia, United States
Advaxis, Inc.

Completed

A Phase 2 Study of Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal Canal

Rectal Cancer | Anal Cancer

United States
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Beijing Defengrei Biotechnology Co.,Ltd

Completed

Safety and Tolerability of BDB-001 Injection in Healthy Subjects

Healthy

China
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Beijing Defengrei Biotechnology Co.,Ltd

Completed

Tolerability and Safety of BDB-001 Injection in Healthy Subjects

Healthy

China
Abbisko Therapeutics Co, Ltd

Enrolling by invitation

A Study to Assess the Safety, Tolerability and Antitumor Activity of X4P-001 in Combination With TNBC

Triple Negative Breast Cancer

China
Hvivo
Prep Biopharm Limited

Completed

Study Examining PrEP-001 in Subjects With Asthma

Asthma
Lisata Therapeutics, Inc.

Completed

NBS10 (Also Known as AMR-001) Versus Placebo Post ST Segment Elevation Myocardial Infarction (PreSERVE-AMI)

ST Segment Elevation Myocardial Infarction

United States
Yaupon Therapeutics

Completed

An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides

Mycosis Fungoides

United States
PharmAbcine

Terminated

TTAC-0001 Phase II Trial With Recurrent Glioblastoma Progressed on Bevacizumab

Recurrent Glioblastoma

Australia, United States
Shiga University
Tokyo University

Completed

Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 or A*02-positive Advanced Solid Tumors

Solid Tumors

Japan
LEO Pharma

Completed

A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp

Actinic Keratosis

United States
Assiut University

Not yet recruiting

Intrathecal Dexamethasone and Atropine on Morphine Induced Post-operative Nausea and Vomiting on Caesarean Section

Morphine Adverse Reaction
Assiut University

Completed

Intrathecal Atropine to Prevent Postoperative Nausea and Vomiting

Postoperative Nausea

Egypt
University of Medicine and Pharmacy at Ho Chi Minh...
Merck Sharp & Dohme LLC

Unknown

Deep Neuromuscular Block and Sugammadex Versus Standard of Care on Quality of Recovery in Patient Undergo Elective Laparoscopic Cholecystectomy

Neuromuscular Block

Vietnam
Yaqrit Ltd
Assistance Publique - Hôpitaux de Paris; IRCCS Azienda Ospedaliero-Universitaria... and other collaborators

Terminated

Safety and Tolerability of Yaq-001 in Patients With Cirrhosis

Liver Cirrhosis

France, Italy, Portugal, Spain, United Kingdom, Switzerland
Galderma R&D

Completed

Tolerability Comparison of Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin

Skin Manifestations

United States
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Study Comparing Efficacy of Doxorubicin With Trabectedin Followed by Trabectedin Versus Doxorubicine in Patients With Leiomyosarcoma (LMS04)

Uterine or Soft Tissue Leiomyosarcoma

France

Search clinical trials for: 0.01% atropine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Egypt

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations